Delivery Order SPE2DB22D3016-SPE2DB24FATW3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, worth $24,988.50, for the supply of PADCEV 30 MG VIALS. This contract is not set aside and has a completion date of June 14, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract is a firm fixed-price delivery order with a ceiling value of $39,998.88 and is set to be completed by September 5, 2024. Amerisourcebergen is providing these critical pharmaceutical products to support military treatment facilities and other federal healthcare providers. This delivery order is part...
- The Defense Logistics Agency awarded a delivery order valued at $14,783.60 to AmerisourceBergen Drug Corp for Padcev 20 mg vials, with a firm fixed price and an ultimate completion date of December 1, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. The...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PADCEV 30 MG vials. The order has a potential value of $116,823.84 and a completion date of June 1, 2023. Amerisourcebergen Drug Corp is a prime contractor that regularly supplies pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical facilities and programs. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $24,338.30 firm fixed price delivery order contract to provide PADCEV 30 MG VIALS. This is a pharmaceutical product delivery order under a larger indefinite delivery contract held by Amerisourcebergen with DLA to supply pharmaceuticals and medical supplies, primarily in support of military treatment programs and facilities. The contract has a completion date of January...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp (ABDC) Corporate Office Division. The contract is for the supply of PADCEV 30 MG vials, a pharmaceutical product. The contract has a total ceiling value of $24,999.30 and is a Firm Fixed Price type. There is no set-aside designation for this award. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,543.85 to AmerisourceBergen Drug Corp for Padcev 20 mg vials on November 4, 2025, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order is non-set-aside and competitively awarded, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $1,699.50 and a completion date of June 13, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $24,052.52 and an ultimate completion date of May 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 13, 2025, a ceiling value of $1,926.60, and is not set aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FATW3Delivery Order
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the provision of 4564441020 PADCEV 30 MG VIALS. The contract has an ultimate completion date of May 20, 2024 and a ceiling value of $9,999.72. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was made on a full and open competition basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 4/29/24 |